joe rogan recommended bpc 157 An FDA advisory panel narrowly voted to ease restrictions on injectable “wellness” peptides like BPC-157 and TB-500, despite FDA scientists warning there's little evidence they're safe or effective. If the FDA follows The ABCs of what Joe

Cross selling

For the broader research view, see the Glow Stack research guide on each compound's role, study context, and safety notes

Choose injectable tirzepatide if: You want the highest probability of significant weight loss You value dose consistency and predictable results You have type 2 diabetes or other metabolic conditions You are comfortable with (or can learn to tolerate) weekly injections You want to use an FDA-approved, clinically validated approach Consider oral tirzepatide if: You have genuine, severe needle phobia that cannot be overcome Physical limitations prevent self-injection Travel requirements make injectable logistics impossible You want to test tolerance before committing to injections You understand and accept the lower and variable bioavailability For most researchers, injectable tirzepatide is the right choice

Blood samples were collected from rats in group five before the last three doses and within 6 h after the last dose